Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where David Gonzalez-Barcena is active.

Publication


Featured researches published by David Gonzalez-Barcena.


Physiology & Behavior | 1971

Psycho-physiologic correlates of MSH activity in man

Abba J. Kastin; Lyle H. Miller; David Gonzalez-Barcena; William D. Hawley; Kjell Dyster-Aas; Andrew V. Schally; M. Luisa Velasco de Parra; Marcos Velasco

Abstract The role of MSH in man is unknown. Administration of 10 mg synthetic alpha melanocyte-stimulating hormone (MSH) to 5 human subjects resulted in a significant increase in the averaged somatosensory cortical evoked response (AER). This change in the amplitude of the somatosensory evoked response was so marked that it could be seen on single trials of the EEG. The AER further increased during attention. Performance on the Benton Visual Retention Test also improved significantly after infusion of MSH. These findings demonstrate extra-pigmentary effects of MSH in man and suggest an effect upon the attentive process.


Neuroendocrinology | 1973

Lack of Effect of Steroids on Thyrotropin-Releasing Hormone (TRH) Mediated Thyrotropin (TSH) Release in Man

Paul Woolf; David Gonzalez-Barcena; Don S. Schalch; Louyse A. Lee; J.P. Arzac; A.V. Schally; A.J. Kastin

Plasma thyrotropin levels were measured after the acute i.v. administration of 400 µg of synthetic thyrotropin-releasing hormone (TRH) in 6 patients with Addison’s disease, 2 patients with thrombo-cyt


The Lancet | 1975

STIMULATION OF LUTEINISING HORMONE (L.H.) RELEASE AFTER ORAL ADMINISTRATION OF AN ANALOGUE OF L.H. RELEASING HORMONE

David Gonzalez-Barcena; M. Clinton Miller; D.H. Coy; AbbaJ Kastin; DonS Schalch; A. V. Schally; Antonio Escalante-Herrera

An analogue of luteinising-hormone-releasing hormone ([D-Leu-6, desGly-NH2-10]-L.H.R.H.-ethylamide) was administered by mouth to thirteen healthy men. In eight men 10 mg of this superactive L.H.R.H. analogue significantly increased mean plasma-L.H. within 45 minutes of administration. This increase was sustained for more than 5 hours. 2 mg of the analogue did not significantly increase plasma-gonadotrophin concentrations in the five men to whom this smaller dose was given. Oral administration of some L.H.R.H. analogues would seem to be effective in releasing L.H. in man.


The Journal of Clinical Endocrinology and Metabolism | 1972

Abnormalities in the Release of TSH in Response to Thyrotropin-Releasing Hormone (TRH) in Patients with Disorders of the Pituitary, Hypothalamus and Basal Ganglia

Don S. Schalch; David Gonzalez-Barcena; Abba J. Kastin; Andrew V. Schally; Louyse A. Lee


The Journal of Clinical Endocrinology and Metabolism | 1975

Plasma gonadotropins after administration of LH releasing hormone in patients with renal or hepatic failure

Don S. Schalch; David Gonzalez-Barcena; Abba J. Kastin; Luis Landa; Louyse A. Lee; Manuel T. Zamora; Andrew V. Schally


The Journal of Clinical Endocrinology and Metabolism | 1973

Synthetic LH-Releasing Hormone (LH-RH) Administered to Normal Men by Different Routes*

David Gonzalez-Barcena; Kastin Aj; Don S. Schalch; Jose A. Bermudez; Daniel Lee; Akira Arimura; Juan Ruelas; Ismael Zepeda; Andrew V. Schally


European Journal of Endocrinology | 1994

Inhibition of luteinizing hormone, follicle-stimulating hormone and sex-steroid levels in men and women with a potent antagonist analog of luteinizing hormone-releasing hormone, Cetrorelix (SB-75)

David Gonzalez-Barcena; Manuel Vadillo Buenfil; Emilo Garcia Procel; Laura Guerra-Arguero; Imelda Cardenas Cornejo; Ana Maria Comaru-Schally; Andrew V. Schally


International Journal of Fertility | 1974

Increased potency of four analogues of LH releasing hormone in man

Kastin Aj; Arimura A; David Gonzalez-Barcena; Coy Dh; Miller Mc; Nishi N; Lee L; Duron-Huerta H; Schalch Ds; Andrew V. Schally


The Journal of Clinical Endocrinology and Metabolism | 1974

Clinical Comparison of Natural LH-RH, Synthetic LH-RH, and Two Analogues of LH-RH

Abba J. Kastin; Andrew V. Schally; David Gonzalez-Barcena; David H. Coy; M. Clinton Miller; Hans Porias; Don S. Schalch


International Journal of Fertility | 1974

Response to LH-RH in women before and after treatment with prednisone.

David Gonzalez-Barcena; Kastin Aj; Schalch Ds; Miller Mc; Lee L; Rivas-Llamas R; Andrew V. Schally

Collaboration


Dive into the David Gonzalez-Barcena's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Don S. Schalch

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kastin Aj

Hospital General de México

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Schalch Ds

Hospital General de México

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

David H. Coy

Hospital General de México

View shared research outputs
Top Co-Authors

Avatar

Don S. Schalch

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Imelda Cardenas Cornejo

Mexican Social Security Institute

View shared research outputs
Researchain Logo
Decentralizing Knowledge